- Application of Poisoning aBIG score for Prediction of Fatal Severity in Acute Adult Intoxications
-
Michael Sung Choe, Jae Yun Ahn, In Gu Kang, Mi Jin Lee
-
J Korean Soc Clin Toxicol. 2014;12(1):14-21. Published online June 30, 2014
-
-
-
 Abstract
 PDF
- Purpose: The objective of this study was to develop a new scoring tool that is comprehensively applicable and predicts fatality within 24 h of intoxication. Methods: This was a cohort study conducted in two emergency medical centers from 2011 to 2012. We identified factors associated with severe/fatality. Through a discriminant analysis, we devised the aBIG (age, Base deficit, Infection, and Glasgow coma scale) score. To compare the ability of aBIG to predict intoxication severity with that of previous scoring systems such as APACHE II, MODS, SAPS IIe, and SOFA, we determined the receiver operating characteristic curves of each variable in predicting severe-to-fatal toxicity. Results: Compared with the mild/moderate toxicity group (n=211), the severe/fatal group (n=143) had higher incidences of metabolic acidosis, infection, serious mental change, QTc prolongation and hepato-renal failure. Age, base deficit, infection-WBC count, and Glasgow Coma Scale were independently associated with severe/fatal poisoning. These variables were combined into the poisoning "aBIG" score [$0.28{ imes}$Age group+$0.38{ imes}WBC$ count/$10^3+0.52{ imes}$Base deficit+$0.64{ imes}$(15-GCS)], which were each calculated to have an area under the curve of 0.904 (95% confidence interval: 0.868-0.933). The aBIG poisoning score had an equivalent level of severity predictability as APACHE II and a superior than MODS, SOFA, and SAPS IIe. Conclusion: We developed a simplified scoring system using the four variables of age, base deficit, infected leukocytosis, and GCS. The poisoning aBIG score was a simple method that could be performed rapidly on admission to evaluate severity of illness and predict fatal severity in patients with acute intoxications.
- A Case of Mental Change in a Patient Who Received a Zoletil Injection
-
Yeong Ki Lee, In Gu Kang, Cheol Sang Park, Seok Jin Heo, Youn Seok Chai, Seong Soo Park, Jae Kwang Lee, Hyun Jin Kim, Won Joon Jeong
-
J Korean Soc Clin Toxicol. 2013;11(1):23-27. Published online June 30, 2013
-
-
-
Abstract
PDF
- Zoletil is a non-opioid, non-barbiturate animal anesthetic and proprietary combination of two drugs, a dissociative anesthetic drug, tiletamine, with the benzodiazepine anxiolytic drug, zolazepam. Zoletil has greater potency than ketamine. Zoletil is abused for recreational purposes, especially by people with easy access to medicine. However, in Korea, it is available over-the-counter. Here we report on a case of an 83-year-old woman who received injection of seven vials of "Zoletil 50" by her daughter and presented with an altered mental change. Her mental state was stupor and vital sign was hypotension, bradycardia. Her blood tests indicated metabolic and respiratory acidosis and hyperkalemia. She was treated with intravenous naloxone and flumazenil but was not responsive. She was admitted to the ICU and treated with supportive therapy. Her mental state showed transient recovery, however, her clinical manifestation worsened and she expired.
|
KSCT
Korean Society of Clinical Toxicology